176 related articles for article (PubMed ID: 33064395)
1. Historical and Contemporary Management of Infantile Hepatic Hemangioma: A 30-year Single-center Experience.
Macdonald A; Durkin N; Deganello A; Sellars ME; Makin E; Davenport M
Ann Surg; 2022 Jan; 275(1):e250-e255. PubMed ID: 33064395
[TBL] [Abstract][Full Text] [Related]
2. Neonatal giant hepatic hemangioma: A case report.
Zhu Z; Cai P; Zhu J; Chen J; Wu B; Gu Z; Huang S; Wang J
Medicine (Baltimore); 2018 Oct; 97(42):e12863. PubMed ID: 30334996
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of hepatic hemangiomas: management and outcome.
Dickie B; Dasgupta R; Nair R; Alonso MH; Ryckman FC; Tiao GM; Adams DM; Azizkhan RG
J Pediatr Surg; 2009 Jan; 44(1):125-33. PubMed ID: 19159729
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of infantile hepatic hemangioma with propranolol treatment: A case report.
Tsai MC; Liu HC; Yeung CY
Medicine (Baltimore); 2019 Jan; 98(4):e14078. PubMed ID: 30681565
[TBL] [Abstract][Full Text] [Related]
6. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
Mhanna A; Franklin WH; Mancini AJ
Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
[TBL] [Abstract][Full Text] [Related]
7. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
8. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature.
Bosemani T; Puttgen KB; Huisman TA; Tekes A
Eur J Pediatr; 2012 Jul; 171(7):1023-8. PubMed ID: 22234480
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma.
Wang L; Li J; Song D; Guo L
Pediatr Surg Int; 2022 Aug; 38(8):1149-1155. PubMed ID: 35708761
[TBL] [Abstract][Full Text] [Related]
10. Infantile Hemangioma: An Updated Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(1):55-69. PubMed ID: 32384034
[TBL] [Abstract][Full Text] [Related]
11. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
Kagami S; Kaneko M; Kishi A; Katori T
J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
[TBL] [Abstract][Full Text] [Related]
12. Postnatal treatment and evolution patterns of giant fetal hepatic hemangioma: a case series of 29 patients.
Xie LL; Huang YB; Dong KR; Yang SB; Shen C; Ma YY
BMC Pediatr; 2024 Jan; 24(1):8. PubMed ID: 38172842
[TBL] [Abstract][Full Text] [Related]
13. [Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
Baranowski S; Winkler A; Kunzi-Rapp K; Schaal M; Hempel S; Debatin KM; Posovszky C
Klin Padiatr; 2012 Oct; 224(6):393-5. PubMed ID: 23143767
[No Abstract] [Full Text] [Related]
14. Effectiveness of Transarterial Embolization in Treatment of Symptomatic Hepatic Hemangiomas: Systematic Review and Meta-analysis.
Torkian P; Li J; Kaufman JA; Jahangiri Y
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):80-91. PubMed ID: 32808203
[TBL] [Abstract][Full Text] [Related]
15. Lessons from a liver hemangioma registry: subtype classification.
Kulungowski AM; Alomari AI; Chawla A; Christison-Lagay ER; Fishman SJ
J Pediatr Surg; 2012 Jan; 47(1):165-70. PubMed ID: 22244411
[TBL] [Abstract][Full Text] [Related]
16. Progressive infantile hepatic hemangioma not responding to propranolol.
Yang K; Feng L; Chen S; Ji Y
J Dermatol; 2019 Aug; 46(8):e275-e276. PubMed ID: 30821839
[No Abstract] [Full Text] [Related]
17. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment results in children with hemangioma.
Ataş E; Koç O; Artık HA
Turk J Pediatr; 2017; 59(3):254-260. PubMed ID: 29376569
[TBL] [Abstract][Full Text] [Related]
19. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
Li XY; Wang Y; Jin L; Chen JR
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
[TBL] [Abstract][Full Text] [Related]
20. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?
Javia LR; Zur KB; Jacobs IN
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1450-4. PubMed ID: 21880377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
